3,569 trials (keyword fallback)
Lip and Oral Cavity Cancer · Oral Leukoplakia · Oropharyngeal Cancer
Primary: Relative Percent Change in Total Lesion Area After 6 Months on Study — -20.6; -17.1 percentage change
Leukoplakia · Erythroplakia
Primary: Maximum Tolerated Dose — 8 J/cm2
Head and Neck Cancer · Oral Leukoplakia
Primary: Patients' Overall Response — 0; 15; 2; 4 Participants
Leukoplakia, Oral
Primary: Best Overall Response Rate (BORR) — 36.4 percentage of participants
Mild Dementia
Primary: Plaque Index — 0.55; 0.41; 0.48 Proportion of sites with plaque deposits — p=0.939
Oral Leukoplakia · Oral Lichen Planus · Premalignant Lesion
Primary: Number and Percentage of Lesions That Were Stained Positive — 29; 28 lesions — p=0.005
Dental Caries
Primary: Early Childhood Caries (ECC) — 8; 41 Participants
Oral Mucositis
Primary: Feasibility of Photo Biomodulation Therapy (PBM) in Reducing Oral Mucositis (OM) in Children and Adolescents at Risk for Grade 3 OM Undergoing an Allogeneic…
Short Bowel Syndrome
Primary: Safety and Tolerability of the Oral RotaTeq® Vaccine — 18; 3 Individual Adverse Events
Periodontal Diseases · Dental Plaque · Dental Calculus
Primary: Gingival Index — 0.7190; 1.1152 units on a scale
Dental Caries
Primary: Dental Attendance — 330; 332; 170; 150 Participants
Retention
Primary: Changes in the Knowledge Score — 4.81; 4.86; 4.64; 7.10 units on a scale — p=<0.001
Heart Failure
Primary: Weight Change Over 48 Hours — -4.6; -5.8; -4.1 kg
Healthy Subjects
Primary: Number (%) of Grade 2 or Higher AEs Regardless of Relationship to Study Drug — 1; 3 Participants
Menorrhagia
Primary: To Assess the Efficacy of Oral TA and COCP in Adolescents With Menorrhagia. — 536.4; 430.6; 15.6; 16.75 Scores on a scale — p=0.01